Apaziquone

DB12593InvestigationalSmall molecule

Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms.

Mechanism: Pharmacologically active on NAD(P)H dehydrogenase [quinone] 1
Curator reviewed
Formula / weight: C₁₅H₁₆N₂O₄ · 288.303 g/mol (avg)
Also known as: EOQUIN
Code names: NOR-701

Resolves to

Compound

Structure

InChIKeyMXPOCMVWFLDDLZ-NSCUHMNNSA-NSMILESCN1C(\C=C\CO)=C(CO)C2=C1C(=O)C=C(N1CC1)C2=O

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Apaziquone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.